medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2022, Número 3

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2022; 20 (3)


Utilidad del láser de baja potencia en alopecia: evidencia científica publicada

Esquerra PO, Macías MAI, Saavedra COG, Capilla GMH, Hernández CAA, Fernández-Crehuet P

Idioma: Español
Referencias bibliográficas: 46
Paginas: 343-349
Archivo PDF: 145.59 Kb.


RESUMEN

Introducción: la fotobiomodulación a través del láser de baja potencia (LLLT) es una terapia emergente en el tratamiento de diversas formas de alopecia; sin embargo, aun cuando es un tratamiento accesible e inocuo, su efectividad clínica no ha sido evaluada de forma regular.
Material y métodos: se realizó una revisión sistemática en las bases de datos para evaluar la efectividad clínica de LLLT.
Resultados: se incluyeron 32 estudios, 42% para alopecia androgénica. El LLLT demostró ser una terapia eficaz en aumento de densidad y grosor de pelo terminal, sin efectos adversos mayores en AGA sin protocolos estandarizados. En alopecia areata se encontró efectividad en actividad de enfermedad y recrecimiento, excepto en formas extensas o establecidas. En alopecias linfocíticas liquenoides, cinco reportes de casos demuestran disminución en síntomas como escama peripilar y mejoría en la percepción cosmética.
Conclusiones: el LLLT es una terapia eficaz y aceptada para algunos tipos de alopecia (sobre todo en AGA), sin efectos adversos mayores.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Chung H, Dai T, Sharma SK, Huang YY, Carroll JD y Hamblin MR, Thenuts and bolts of low-level laser (light) therapy, Ann Biomed Eng Online 2012; 40: 516-33.

  2. Gupta A, Dai T y Hamblin MR, Effect of red and near-infraredwavelengths on low-level laser (light) therapy-induced healing ofpartial-thickness dermal abrasion in mice, Lasers Med Sci 2014; 29:257-65.

  3. AlGhamdi KM, Kumar A y Moussa NA, Low-level laser therapy: a usefultechnique for enhancing the proliferation of various cultured cells,Lasers Med Sci 2012; 27:237-49.

  4. Desai S, Mahmoud BH, Bhatia AC y Hamzavi IH, Paradoxical hypertrichosisafter laser therapy: a review, Dermatol Surg 2010; 36: 291-8.

  5. Mester A y Mester A, The history of photobiomodulation: EndreMester (1903-1984), Photomed Laser Surg 2017; 35:393-4.

  6. Bouzari N y Firooz AR, Lasers may induce terminal hair growth, DermatolSurg 2006; 32:460.

  7. Wikramanayake TC, Rodríguez R, Choudhary S, Mauro LM, Nouri K,Schachner LA y Jiménez JJ, Effects of the Lexington LaserComb onhair regrowth in the c3h/hej mouse model of alopecia areata, LasersMed Sci 2012; 27: 431-6.

  8. Avram MR, Leonard RT, Epstein ES, Williams JL y Bauman AJ. Thecurrent role of laser/light sources in the treatment of male and femalepattern hair loss, J Cosmetic Laser Ther 2007; 9: 27-8.

  9. Avram MR y Rogers NE, The use of low-level light for hair growth:part i, J Cosmet Laser Ther 2009; 11:110-7.

  10. Leavitt M, Charles G, Heyman E y Michaels D, HairMax LaserComblaser phototherapy device in the treatment of male androgenetic alopecia:a randomized, double-blind, sham device-controlled, multicentretrial, Clin Drug Investig 2009; 29(5):283-92.

  11. King LE Jr, Silva KA, Kennedy VE y Sundberg JP, Lack of response tolaser comb in spontaneous and graft-induced alopecia areata in c3h/hej mice, J Invest Dermatol 2014; 134:264-6.

  12. Wikramanayake TC, Villasante AC, Mauro LM, Nouri K, Schachner LA,Pérez CI y Jiménez JJ, Low-level laser treatment accelerated hair regrowthin a rat model of chemotherapy-induced alopecia (cia), LaserMed Sci 2013; 28:701-6.

  13. Fonda-Pascual P, Moreno-Arrones OM, Saceda-Corralo D, Rodrigues-Barata AR, Pindado-Orteg C, Boixeda P y Vañó-Galván S, Effectivenessof low-level laser therapy in lichen planopilaris, J Am Acad Dermatol2018; 78:1020-3.

  14. Gerkowicz A, Bartosin´ska J, Wolska-Gawron K, Michalska-Jakubus M,Kwas´ny M y Krasowska D, Application of superluminescent diodes(sled) in the treatment of scarring alopecia: a pilot study, Photodiag andPhotodyn Ther 2019; 28:195-200.

  15. Randolph MJ, Al Salhi W y Tosti A, Lichen planopilaris and low-levellight therapy: four case reports and review of the literature aboutlow-level light therapy and lichenoid dermatosis, Dermatol 2020; 1-9.

  16. Kazemikhoo N y Mansouri P, Successful treatment of resistant discoidlupus erythematous (dle) with low-level laser therapy (lllt): a casereport, J Skin Stem Cell 2016; 3:1.

  17. Kim CY, Seo HS, Lee DJ y Kwon K, Case study on treating scarringalopecia and alopecia arreata using low level laser therapy and acupuncture,J Korean Med Ophthalm Otol Dermatol 2016; 29:182-8.

  18. Avci P, Gupta GK, Clark J, Wikonkal N y Hamblin MR, Low-level laser(light) therapy (lllt) for treatment of hair loss, Lasers Surg Med 2014;46:144-51.

  19. Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A yNast A, Evidence-based (s3) guideline for the treatment of androgeneticalopecia in women and in men: short version, J Eur Acad DermatolVenereol 2018; 32: 11-22.

  20. Adil A y Godwin M, The effectiveness of treatments for androgeneticalopecia: a systematic review and meta-analysis, J Am Acad Dermatol2017; 77:136-41.

  21. Orasan MS, Coneac A, Mihu CM, Mare C y Muresan A, Minoxidil andneoptide topical application reinforced by low-level laser therapy onan animal model of alopecia, Stu Chem 2015; 60:295-308.

  22. Rossi A, Cantisani C, Melis L, Iorio A, Scali E y Calvieri S, Minoxidil use indermatology, side effects and recent patents, Recent Pat Inflamm AllergyDrug Discov 2012; 6: 130-6.

  23. Han L, Liu B, Chen X, Chen H, Deng W, Yang C y Wan M, Activationof Wnt/β-catenin signaling is involved in hair growth-promoting effectof 655-nm red light and led in vitro culture model, Lasers Med Sci2018; 33:637-45.

  24. Panchaprateep R, Pisitkun T y Kalpongnukul N, Quantitative proteomicanalysis of dermal papilla from male androgenetic alopeciacomparing before and after treatment with low-level laser therapy,Lasers Surg Med 2019; 51:600-8.

  25. Gupta AK y Carviel JL, Meta-analysis of photobiomodulation for thetreatment of androgenetic alopecia, J Dermatol Treat 2019; 1-5.

  26. Wang S, Seth D, Ezaldein H, Tripathi R, Merati M, Muakkassa F y ScottJ, Shedding light on the fda’s 510 (k) approvals process: low-level lasertherapy devices used in the treatment of androgenetic alopecia, JDermatol Treat 2018; 30:489-91.

  27. Pindado-Ortega C, Saceda-Corralo D, Buendía-Castaño D, Fernández-González P, Moreno-Arrones ÓM, Fonda-Pascual P y Vañó-Galván S,Estudio transversal acerca de los hábitos de prescripción en alopeciaandrogénica de los dermatólogos en España en 2017, Actas Dermosifiliogr2018; 109:536-42.

  28. Kim TH, Kim NJ y Youn JI, Evaluation of wavelength-dependent hairgrowth effects on low-level laser therapy: an experimental animalstudy, Laser Med Sci 2015; 30:1703-9.

  29. Shin H, Jo SJ, Kim DH, Kwon O y Myung SK, Efficacy of interventionsfor prevention of chemotherapy-induced alopecia: a systematicreview and meta-analysis, Int J Cancer 2015; 136:442-54.

  30. Yamazaki M, Miura Y, Tsuboi R y Ogawa H, Linear polarized infraredirradiation using Super Lizer is an effective treatment for multipletypealopecia areata, Int J Dermatol 2003; 42:738-40.

  31. Waiz M, Saleh AZ, Hayani R y Jubory SO, Use of the pulsed infrareddiode laser (904 nm) in the treatment of alopecia areata, J Cosm Laser2006, 8:27-30.

  32. Abdelhalim NM, Efficacy of low level laser therapy in the treatmentof alopecia areata, Int J Physiother Res 2014; 2:460-5.

  33. Satino JL y Markou M, Hair regrowth and increased hair tensilestrength using the HairMax LaserComb for low-level laser therapy, IntJ Cos Surg Aest Dermatol 2003; 5:113-7.

  34. Kim H, Choi JW, Kim JY, Shin JW, Lee SJ y Huh CH, Low level lighttherapy for androgenetic alopecia: a 24-week, randomized, doubleblind.Sham device-controlled multicenter trial, Dermatol Surg 2013;39(8):1177-83.

  35. Lanzafame RJ, Blanche RR, Chiacchierini RP, Kazmirek ER y Sklar JA,The growth of human scalp hair in females using visible red light laserand led sources, Lasers Surg Med 2014; 46:601-7.

  36. Lanzafame RJ, Blanche RR, Bodian AB, Chiacchierini RP, Fernández-Obregón A y Kazmirek ER, The growth of human scalp hair mediatedby visible red light laser and led sources in males, Lasers Surg Med 2013;45:487-95.

  37. Jiménez JJ, Wikramanayake TC y Bergfeld W, Efficacy and safety ofa low-level laser device in the treatment of male and female patternhair loss: a multicenter, randomized, sham device-controlled, doubleblindstudy, Am J Clin Dermatol 2014; 15:115-27.

  38. Tabaie SM, Berenji Ardestani H y Azizjalali MH, The effect of onesession low level laser therapy of extracted follicular units on the outcomeof hair transplantation, J Lasers Med Sci 2016; 7:26-9.

  39. Barikbin B, Khodamrdi Z, Kholoosi L, Akhgri MR, Haj Abbasi M,Hajabbasi M y Akbarpour S, Comparison of the effects of 665 nmlow level diode Laser Hat versus and a combination of 665 nm and808 nm low level diode Laser Scanner of hair growth in androgenicalopecia, Journal of Cosmetic and Laser Therapy 2017. doi: 10.1080/14764172.2017.1326609.

  40. Munck A, Gavazzoni MF y Trueb RM, Use of low-level laser therapyas monotherapy or concomitant therapy for male and female androgeneticalopecia, Int J Trichology 2014; 6:45-9.

  41. Esmat SM, Hegazy RA, Gawdat HI, Abdel Hay RM, Allam RS, ElNaggar R y Moneib H, Low level light-minoxidil 5% combination versuseither therapeutic modality alone in management of female patternedhair loss: a randomized controlled study, Lasers Surg Med 2017;49:835-43.

  42. Friedman S y Schnoor P, Novel approach to treating androgenetic alopeciain females with photobiomodulation (low-level laser therapy),Dermatol Surg 2017; 43:856-67.

  43. Suchonwanit P, Chalermroj N y Khunkhet S, Low-level laser therapyfor the treatment of androgenetic alopecia in Thai men and women:a 24-week, randomized, double-blind, sham device-controlled trial,Lasers Med Sci 2019; 34:1107-14.

  44. Mai-Yi Fan S, Cheng YP, Lee MY, Lin SJ y Chiu HY, Efficacy and safetyof a low-level light therapy for androgenetic alopecia: a 24-week, randomized,double-blind, self-comparison, sham device-controlled trial,Dermatol Surg 2018; 44:1411-20.

  45. García PN, Andrino RL, Gómez C y González HP, Use of helmet withcombined low-level laser therapy, light-emitting diodes, and magneticfield technologies for hair growth treatments of male androgenic alopeciain adult patients,uime 2019; 5:16.

  46. Gentile P, Dionisi L, Pizzicannella J, De Angelis B, De Fazio D y GarcovichS, A randomized blinded retrospective study: the combineduse of micro-needling technique, low-level laser therapy and autologousnon-activated platelet-rich plasma improves hair re-growthin patients with androgenic alopecia, Expert Opin Biol Ther 2020; 20:1099-109.




2020     |     www.medigraphic.com